Global and Europe T-Cell Immunotherapy Market Professional Survey Report 2019

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Global T-Cell Immunotherapy market was valued at XX.0 million US$ in 2018, with the CAGR of 4.0%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe T-Cell Immunotherapy market. Describe product range of T-Cell Immunotherapy, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe T-Cell Immunotherapy market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe T-Cell Immunotherapy market.

     

    By Player

    • Cellectis

    • Juno Therapeutics

    • Novartis

    • Takara Bio

    • Altor Bioscience Corporation

    • Biotecnol

    • Adaptimmune

    • Unum Therapeutics

    • Kite Pharma

    By Type

    • CAR-T

    • TCR

    • TIL Therapies

    By End-User

    • Stomach Cancer

    • Lung Cancer

    • Colorectal Cancer

    • Esophagus Cancer

    • Pancreatic Cancer

    • Others

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of T-Cell Immunotherapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

      • 1.3.2 Global T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

      • 1.3.3 Global T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

      • 1.4.2 Global T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

      • 1.4.3 Global T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

      • 1.4.4 Global T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

      • 1.4.5 Global T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

      • 1.4.6 Global T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA T-Cell Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of T-Cell Immunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of T-Cell Immunotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of CAR-T

      • 3.4.2 Market Size and Growth Rate of TCR

      • 3.4.3 Market Size and Growth Rate of TIL Therapies

    4 Segmentation of T-Cell Immunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of T-Cell Immunotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of T-Cell Immunotherapy for Stomach Cancer

      • 4.4.2 Market Size and Growth Rate of T-Cell Immunotherapy for Lung Cancer

      • 4.4.3 Market Size and Growth Rate of T-Cell Immunotherapy for Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of T-Cell Immunotherapy for Esophagus Cancer

      • 4.4.5 Market Size and Growth Rate of T-Cell Immunotherapy for Pancreatic Cancer

      • 4.4.6 Market Size and Growth Rate of T-Cell Immunotherapy for Others

    5 Market Analysis by Major Regions

    • 5.1 Global T-Cell Immunotherapy Production Analysis by Top Regions

    • 5.2 Global T-Cell Immunotherapy Consumption Analysis by Top Regions

    • 5.3 Global T-Cell Immunotherapy Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    6 Product Circulation of T-Cell Immunotherapy Market among Top Countries

    • 6.1 Top 5 Export Countries in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America T-Cell Immunotherapy Landscape Analysis

    • 7.1 North America T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 7.1.1 United States T-Cell Immunotherapy Market Volume and Growth Rate

      • 7.1.2 Canada T-Cell Immunotherapy Market Volume and Growth Rate

      • 7.1.3 Mexico T-Cell Immunotherapy Market Volume and Growth Rate

    8. Europe T-Cell Immunotherapy Landscape Analysis

    • 8.1 Europe T-Cell Immunotherapy Landscape Analysis by Major Types

    • 8.2 Europe T-Cell Immunotherapy Landscape Analysis by Major End-Users

    • 8.3 Europe T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 8.3.1 Germany T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.2 UK T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.3 France T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.4 Italy T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.5 Spain T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.6 Belgium T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.7 Poland T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.8 Russia T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.9 Turkey T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.10 Netherlands T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.11 Portugal T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.12 Denmark T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.13 Finland T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.14 Iceland T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.15 Norway T-Cell Immunotherapy Market Volume and Growth Rate

      • 8.3.16 Sweden T-Cell Immunotherapy Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific T-Cell Immunotherapy Landscape Analysis

    • 9.1 Asia Pacific T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 9.1.1 China T-Cell Immunotherapy Market Volume and Growth Rate

      • 9.1.2 Japan T-Cell Immunotherapy Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) T-Cell Immunotherapy Market Volume and Growth Rate

      • 9.1.4 India T-Cell Immunotherapy Market Volume and Growth Rate

      • 9.1.5 ASEAN T-Cell Immunotherapy Market Volume and Growth Rate

      • 9.1.6 South Korea T-Cell Immunotherapy Market Volume and Growth Rate

    10 LAMEA T-Cell Immunotherapy Landscape Analysis

    • 10.1 LAMEA T-Cell Immunotherapy Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries T-Cell Immunotherapy Market Volume and Growth Rate

      • 10.1.2 Brazil T-Cell Immunotherapy Market Volume and Growth Rate

      • 10.1.3 North Africa T-Cell Immunotherapy Market Volume and Growth Rate

      • 10.1.4 South Africa T-Cell Immunotherapy Market Volume and Growth Rate

      • 10.1.5 Argentina T-Cell Immunotherapy Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Cellectis

      • 11.1.1 Cellectis Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Juno Therapeutics

      • 11.2.1 Juno Therapeutics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Novartis

      • 11.3.1 Novartis Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Takara Bio

      • 11.4.1 Takara Bio Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Altor Bioscience Corporation

      • 11.5.1 Altor Bioscience Corporation Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Biotecnol

      • 11.6.1 Biotecnol Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Adaptimmune

      • 11.7.1 Adaptimmune Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Unum Therapeutics

      • 11.8.1 Unum Therapeutics Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Kite Pharma

      • 11.9.1 Kite Pharma Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 91 Figures and 118 Tables)

    • Figure Product Picture

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of CAR-T from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TCR from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of TIL Therapies from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Stomach Cancer from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Esophagus Cancer from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

    • Figure Global T-Cell Immunotherapy Market Size and Growth Rate of Others from 2014 to 2026

    • Figure North America T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure United States T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Canada T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Europe T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Germany T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure UK T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure France T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Italy T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Spain T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Poland T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Russia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure China T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Japan T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Australia T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure India T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure GCC T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina T-Cell Immunotherapy Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of T-Cell Immunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of T-Cell Immunotherapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of T-Cell Immunotherapy by Different Types from 2014 to 2026

    • Table Consumption Share of T-Cell Immunotherapy by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CAR-T

    • Figure Market Size and Growth Rate of TCR

    • Figure Market Size and Growth Rate of TIL Therapies

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

    • Table Consumption Share of T-Cell Immunotherapy by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Stomach Cancer

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Esophagus Cancer

    • Figure Market Size and Growth Rate of Pancreatic Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Global T-Cell Immunotherapy Production by Major Regions

    • Table Global T-Cell Immunotherapy Production Share by Major Regions

    • Table Global T-Cell Immunotherapy Consumption by Major Regions

    • Table Global T-Cell Immunotherapy Consumption Share by Major Regions

    • Table North America T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Europe T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Asia Pacific T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table LAMEA T-Cell Immunotherapy Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in T-Cell Immunotherapy Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table North America T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2014

    • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2018

    • Figure North America T-Cell Immunotherapy Consumption Share by Major Countries in 2026

    • Figure United States T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption by Types from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption Share by Types from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption by End-Users from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption Share by End-Users from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Europe T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure UK T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure France T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure China T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure India T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa T-Cell Immunotherapy Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries T-Cell Immunotherapy Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Cellectis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis

    • Figure Sales and Growth Rate Analysis of Cellectis

    • Figure Revenue and Market Share Analysis of Cellectis

    • Table Product and Service Introduction of Cellectis

    • Table Company Profile and Development Status of Juno Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics

    • Figure Revenue and Market Share Analysis of Juno Therapeutics

    • Table Product and Service Introduction of Juno Therapeutics

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Takara Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio

    • Figure Sales and Growth Rate Analysis of Takara Bio

    • Figure Revenue and Market Share Analysis of Takara Bio

    • Table Product and Service Introduction of Takara Bio

    • Table Company Profile and Development Status of Altor Bioscience Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Altor Bioscience Corporation

    • Figure Sales and Growth Rate Analysis of Altor Bioscience Corporation

    • Figure Revenue and Market Share Analysis of Altor Bioscience Corporation

    • Table Product and Service Introduction of Altor Bioscience Corporation

    • Table Company Profile and Development Status of Biotecnol

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotecnol

    • Figure Sales and Growth Rate Analysis of Biotecnol

    • Figure Revenue and Market Share Analysis of Biotecnol

    • Table Product and Service Introduction of Biotecnol

    • Table Company Profile and Development Status of Adaptimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune

    • Figure Sales and Growth Rate Analysis of Adaptimmune

    • Figure Revenue and Market Share Analysis of Adaptimmune

    • Table Product and Service Introduction of Adaptimmune

    • Table Company Profile and Development Status of Unum Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unum Therapeutics

    • Figure Sales and Growth Rate Analysis of Unum Therapeutics

    • Figure Revenue and Market Share Analysis of Unum Therapeutics

    • Table Product and Service Introduction of Unum Therapeutics

    • Table Company Profile and Development Status of Kite Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma

    • Figure Sales and Growth Rate Analysis of Kite Pharma

    • Figure Revenue and Market Share Analysis of Kite Pharma

    • Table Product and Service Introduction of Kite Pharma

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.